CTI BioPharma (CTIC) Reports Q2 EPS of $0.03
CTI BioPharma (NASDAQ: CTIC) reported Q2 EPS of $0.03, versus ($0.71) reported last year.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
CTI BioPharma (NASDAQ: CTIC) reported Q2 EPS of $0.03, versus ($0.71) reported last year.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.